Literature DB >> 23359380

Teaching Video NeuroImages: myokymia and nerve hyperexcitability as components of Morvan syndrome due to malignant thymoma.

Rimas V Lukas1, Kourosh Rezania, Monica Malec, Ravi Salgia.   

Abstract

A 50-year-old woman with a history of metastatic malignant thymoma presented with diffuse neuropathic pain involving the extremities and torso prior to chemotherapy and radiation. She also developed episodic diarrhea, diaphoresis, fevers, insomnia, and encephalopathy. Examination revealed rippling muscles (video on the Neurology® Web site at www.neurology.org). Prolonged afterdischarges were noted in motor nerve studies, suggestive for nerve hyperexcitability (figures 1 and 2). Electromyography (approximately 8 years after mediastinal radiation) revealed fasciculations, doublets, triplets, and myokymic discharges. Elevated serum antibodies for voltage-gated potassium channel (0.30 nmol/L, normal <0.02) and striational muscle (1:30,720, normal <1:60) were suggestive of paraneoplastic Morvan syndrome, which includes all of the features noted in our case.(1,2) The CNS features of Morvan syndrome differentiate it from Isaac syndrome, which is most often due to an autoimmune etiology. A substantial proportion of Morvan syndrome cases are paraneoplastic, the majority of which are due to thymomas.(1).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23359380     DOI: 10.1212/WNL.0b013e31827f0fa1

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  2 in total

1.  Paraneoplastic Morvan's syndrome following surgical treatment of recurrent thymoma: A case report.

Authors:  Edvina Galié; Rosaria Renna; Domenico Plantone; Andrea Pace; Mirella Marino; Bruno Jandolo; Tatiana Koudriavtseva
Journal:  Oncol Lett       Date:  2016-07-29       Impact factor: 2.967

2.  Afterdischarges following M waves in patients with voltage-gated potassium channels antibodies.

Authors:  Jingwen Niu; Hongzhi Guan; Liying Cui; Yuzhou Guan; Mingsheng Liu
Journal:  Clin Neurophysiol Pract       Date:  2017-03-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.